Perigon Pharmacy 360 Named Exclusive Specialty Provider for Generic Deflazacort Oral Suspension

PITTSBURGH, June 6, 2024 /PRNewswire/ – Perigon Pharmacy 360, a leading provider of specialized pharmacy services for rare and complex conditions, proudly announces its exclusive partnership as the designated specialty pharmacy for the newly released generic deflazacort oral suspension, for the treatment of Duchenne muscular dystrophy (DMD). This partnership marks a significant stride in accessible healthcare solutions while reinforcing Perigon Pharmacy 360’s unwavering dedication to delivering affordable treatments without compromising quality.

Ted Mills, CEO of Perigon Pharmacy 360, expressed gratitude, stating, “We are privileged to be chosen as the sole specialty pharmacy for generic deflazacort oral suspension. This collaboration with Cranbury Pharmaceuticals enables us to extend vital treatment options to patients at a reduced cost. Our mission remains steadfast: ensuring every patient receives necessary medications without financial burdens.”

Perigon Pharmacy 360 commits to offering comprehensive patient support services, including:

Insurance Advocacy: Streamlined assistance in navigating insurance complexities to secure coverage and minimize out-of-pocket expenses.

Convenient Delivery: Effortless doorstep delivery of medications, eliminating logistical challenges for patients.

Treatment Adherence: Automated refill reminders to foster consistency in treatment adherence.

Bridge Program: Provision of interim medication supply for patients awaiting insurance approval, ensuring uninterrupted therapy.

Financial Aid Programs: Access to financial assistance and co-pay support for eligible patients, further easing financial strain.

Moreover, Perigon Pharmacy 360 leverages the Cranbury Connects program to furnish additional guidance, ensuring patients and caregivers receive comprehensive support to manage their treatment effectively.

Ted Mills emphasized the broader impact of generic deflazacort availability, stating, “The introduction of generic deflazacort signifies a significant stride for healthcare accessibility. Our commitment remains resolute in delivering unparalleled care and support, enabling patients to prioritize their health and well-being.”

For more information on how to prescribe generic Deflazacort Oral Suspension through Perigon Pharmacy 360, visit [www.cranburypharma.com/patients](http://www.cranburypharma.com/patients) or contact us via phone at 844-311-4181 or fax at 844-582-5332.

About Perigon Pharmacy 360

Perigon Pharmacy 360 is a leading specialty pharmacy dedicated to providing comprehensive medication management and support services. With a focus on rare and chronic conditions, Perigon Pharmacy 360 ensures that patients receive the highest level of care, access to essential medications, and dedicated support throughout their treatment journey.

Media Contact:

Will Johnson

Director of Account Management

Perigon Pharmacy 360

Phone: 615-707-0338

Email: will.johnson@perigonhealth.org